GSK-3β is dephosphorylated by PP2A in a Leu309 methylation-independent manner

Journal of Alzheimer's Disease

Volumn 49, Issue 2, 2015, Pages 365-375

  Chu, Dandan ^a   Tan, Jianxin ^a   Xie, Shutao ^a,b   Jin, Nana ^a,b   Yin, Xiaomin ^a   Gong, Cheng Xin ^b   Iqbal, Khalid ^b   Liu, Fei ^a,b  

^a NANTONG UNIVERSITY   (China)

^b NEW YORK STATE INSTITUTE FOR BASIC RESEARCH IN DEVELOPMENTAL DISABILITIES   (United States)

Author keywords

GSK 3 ; methylation; phosphorylation; PP2A

Indexed keywords

BRAIN EXTRACT; ENZYME; GLYCOGEN SYNTHASE KINASE 3BETA; KAINIC ACID; LEUCINE; PHOSPHOPROTEIN PHOSPHATASE INHIBITOR; PROTEIN PHOSPHATE 2A; SERINE; UNCLASSIFIED DRUG; AMINO ACID RECEPTOR STIMULATING AGENT; CARBOXYLESTERASE; ENZYME INHIBITOR; FLUORESCENT PROTEIN 583; GLYCOGEN SYNTHASE KINASE 3; GLYCOGEN SYNTHASE KINASE 3 BETA; LCMT1 PROTEIN, MOUSE; PHOSPHOPROTEIN PHOSPHATASE 2; PHOTOPROTEIN; PROTEIN METHYLTRANSFERASE; PROTEIN PHOSPHATASE METHYLESTERASE-1; SMALL INTERFERING RNA; TAU PROTEIN;

ADULT; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME ACTIVE SITE; ENZYME ACTIVITY; EXCITOTOXICITY; HUMAN; HUMAN CELL; IN VITRO STUDY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEPHOSPHORYLATION; PROTEIN METHYLATION; PROTEIN PROTEIN INTERACTION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; ANIMAL; BRAIN; DOSE RESPONSE; DRUG EFFECTS; GENETICS; METABOLISM; METHYLATION; PHOSPHORYLATION; TRANSFORMED CELL LINE;

ANIMALS; BRAIN; CARBOXYLIC ESTER HYDROLASES; CELL LINE, TRANSFORMED; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; EXCITATORY AMINO ACID AGONISTS; GLYCOGEN SYNTHASE KINASE 3; HUMANS; KAINIC ACID; LEUCINE; LUMINESCENT PROTEINS; MALE; METHYLATION; MICE; PHOSPHORYLATION; PROTEIN O-METHYLTRANSFERASE; PROTEIN PHOSPHATASE 2; RNA, SMALL INTERFERING; SERINE; TAU PROTEINS;

EID: 84948703497     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-150497     Document Type: Article

References (48)

1. Jope RS, Johnson GV (2004) The glamour and gloom of glycogen synthase kinase-3. Trends Biochem Sci 29, 95-102.
2. Lau KF, Miller CC, Anderton BH, Shaw PC (1999) Expression analysis of glycogen synthase kinase-3 in human tissues. J Pept Res 54, 85-91.
3. Lovestone S, Reynolds CH, Latimer D, Davis DR, Anderton BH, Gallo JM, Hanger D, Mulot S, Marquardt B, Stabel S, et al. (1994) Alzheimer's disease-like phosphorylation of the microtubule-Associated protein tau by glycogen synthase kinase-3 in transfected mammalian cells. Curr Biol 4, 1077-1086.
4. Liu F, Li B, Tung EJ, Grundke-Iqbal I, Iqbal K, Gong CX (2007) Site-specific effects of tau phosphorylation on its microtubule assembly activity and self-Aggregation. Eur J Neurosci 26, 3429-3436.
5. Wang JZ, Wu Q, Smith A, Grundke-Iqbal I, Iqbal K (1998) Tau is phosphorylated by GSK-3 at several sites found in Alzheimer disease and its biological activity markedly inhibited only after it is prephosphorylated by A-kinase. FEBS Lett 436, 28-34.
6. Pei JJ, Braak E, Braak H, Grundke-Iqbal I, Iqbal K, Winblad B, Cowburn RF (1999) Distribution of active glycogen synthase kinase 3beta (GSK-3beta) in brains staged for Alzheimer disease neurofibrillary changes. J Neuropathol Exp Neurol 58, 1010-1019.
7. Leroy K, Yilmaz Z, Brion JP (2007) Increased level of active GSK-3beta in Alzheimer's disease and accumulation in argyrophilic grains and in neurones at different stages of neurofibrillary degeneration. Neuropathol Appl Neurobiol 33, 43-55.
8. Llorens-Martin M, Jurado J, Hernandez F, Avila J (2014) GSK-3beta, a pivotal kinase in Alzheimer disease. Front Mol Neurosci 7, 46.
9. Cross DA, Alessi DR, Cohen P, Andjelkovich M, Hemmings BA(1995) Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B. Nature 378, 785-789.
10. Fang X, Yu SX, Lu Y, Bast RC Jr, Woodgett JR, Mills GB (2000) Phosphorylation and inactivation of glycogen synthase kinase 3 by protein kinase A. Proc Natl Acad Sci U S A 97, 11960-11965.
11. Etienne-Manneville S, Hall A (2003) Cdc42 regulates GSK-3beta and adenomatous polyposis coli to control cell polarity. Nature 421, 753-756.
12. Lee CW, Lau KF, Miller CC, Shaw PC (2003) Glycogen synthase kinase-3 beta-mediated tau phosphorylation in cultured cell lines. Neuroreport 14, 257-260.
13. Baki L, Shioi J, Wen P, Shao Z, Schwarzman A, Gama-Sosa M, Neve R, Robakis NK (2004) PS1 activates PI3K thus inhibiting GSK-3 activity and tau overphosphorylation: Effects of FAD mutations. EMBO J 23, 2586-2596.
14. Martinez A, Castro A, Dorronsoro I, AlonsoM(2002) Glycogen synthase kinase 3 (GSK-3) inhibitors as new promising drugs for diabetes, neurodegeneration, cancer, and inflammation. Med Res Rev 22, 373-384.
15. Morfini G, Szebenyi G, Brown H, Pant HC, Pigino G, deboer S, Beffert U, Brady ST (2004)Anovel CDK5-dependent pathway for regulating GSK3 activity and kinesin-driven motility in neurons. EMBO J 23, 2235-2245.
16. Lee YI, Seo M, Kim Y, Kim SY, Kang UG, Kim YS, Juhnn YS (2005) Membrane depolarization induces the undulating phosphorylation/dephosphorylation of glycogen synthase kinase 3beta, and this dephosphorylation involves protein phosphatases 2A and 2B in SH-SY5Y human neuroblastoma cells. J Biol Chem 280, 22044-22052.
17. Sutherland C, Leighton IA, Cohen P (1993) Inactivation of glycogen synthase kinase-3 beta by phosphorylation: New kinase connections in insulin and growth-factor signalling. Biochem J 296(Pt 1), 15-19.
18. Virshup DM, Shenolikar S (2009) From promiscuity to precision: Protein phosphatases get a makeover. Mol Cell 33, 537-545.
19. Liu F, Grundke-Iqbal I, Iqbal K, Gong CX (2005) Contributions of protein phosphatases PP1, PP2A, PP2B and PP5 to the regulation of tau phosphorylation. Eur J Neurosci 22, 1942-1950.
20. Gong CX, Singh TJ, Grundke-Iqbal I, Iqbal K (1993) Phosphoprotein phosphatase activities in Alzheimer disease brain. J Neurochem 61, 921-927.
21. Chen J, Martin BL, Brautigan DL (1992) Regulation of protein serine-Dhreonine phosphatase type-2A by tyrosine phosphorylation. Science 257, 1261-1264.
22. Ogris E, Gibson DM, Pallas DC (1997) Protein phosphatase 2A subunit assembly: The catalytic subunit carboxy terminus is important for binding cellular B subunit but not polyomavirus middle tumor antigen. Oncogene 15, 911-917.
23. Janssens V, Longin S, Goris J (2008) PP2A holoenzyme assembly: In cauda venenum (the sting is in the tail). Trends Biochem Sci 33, 113-121.
24. Longin S, Zwaenepoel K, Louis JV, Dilworth S, Goris J, Janssens V (2007) Selection of protein phosphatase 2A regulatory subunits is mediated by the C terminus of the catalytic Subunit. J Biol Chem 282, 26971-26980.
25. Lee J, Chen Y, Tolstykh T, Stock J (1996) A specific protein carboxyl methylesterase that demethylates phosphoprotein phosphatase 2A in bovine brain. Proc Natl Acad Sci U S A 93, 6043-6047.
26. Ogris E, Du X, Nelson KC, Mak EK, Yu XX, Lane WS, Pallas DC (1999) A protein phosphatase methylesterase (PME-1) is one of several novel proteins stably associating with two inactive mutants of protein phosphatase 2A. J Biol Chem 274, 14382-14391.
27. Zhou XW, Gustafsson JA, Tanila H, Bjorkdahl C, Liu R, Winblad B, Pei JJ (2008) Tau hyperphosphorylation correlates with reduced methylation of protein phosphatase 2A. Neurobiol Dis 31, 386-394.
28. Sontag E, Nunbhakdi-Craig V, Sontag JM, Diaz-Arrastia R, Ogris E, Dayal S, Lentz SR, Arning E, Bottiglieri T (2007) Protein phosphatase 2A methyltransferase links homocysteine metabolism with tau and amyloid precursor protein regulation. J Neurosci 27, 2751-2759.
29. Wang Y, Yang R, Gu J, Yin X, Jin N, Xie S, Chang H, Qian W, Shi J, Iqbal K, Gong CX, Cheng C, Liu F (2015) Cross talk between PI3K-AKT-GSK-3beta and PP2A pathways determines tau hyperphosphorylation. Neurobiol Aging 36, 188-200.
30. Liang Z, Liu F, Iqbal K, Grundke-Iqbal I, Gong CX (2009) Dysregulation of tau phosphorylation in mouse brain during excitotoxic damage. J Alzheimers Dis 17, 531-539.
31. Gong CX, Shaikh S, Grundke-Iqbal I, Iqbal K (1996) Inhibition of protein phosphatase-2B (calcineurin) activity towards Alzheimer abnormally phosphorylated tau by neuroleptics. Brain Res 741, 95-102.
32. Cohen P (1991) Classification of protein-serine/threonine phosphatases: Identification and quantitation in cell extracts. Methods Enzymol 201, 389-398.
33. Hernandez F, Langa E, Cuadros R, Avila J, Villanueva N (2010) Regulation of GSK3 isoforms by phosphatases PP1 and PP2A. Mol Cell Biochem 344, 211-215.
34. Sontag JM, Sontag E (2014) Protein phosphatase 2A dysfunction in Alzheimer's disease. Front Mol Neurosci 7, 16.
35. Sontag E, Luangpirom A, Hladik C, Mudrak I, Ogris E, Speciale S, White CL, 3rd (2004) Altered expression levels of the protein phosphatase 2A abalphac enzyme are associated with Alzheimer disease pathology. J Neuropathol Exp Neurol 63, 287-301.
36. Sontag E, Hladik C, Montgomery L, Luangpirom A, Mudrak I, Ogris E, White CL, 3rd (2004) Downregulation of protein phosphatase 2A carboxyl methylation and methyltransferase may contribute to Alzheimer disease pathogenesis. J Neuropathol Exp Neurol 63, 1080-1091.
37. Sontag JM, Nunbhakdi-Craig V, White CL, 3rd, Halpain S, Sontag E (2012) The protein phosphatase PP2A/Balpha binds to the microtubule-Associated proteins tau and MAP2 at a motif also recognized by the kinase Fyn: Implications for tauopathies. J Biol Chem 287, 14984-14993.
38. Sontag JM, Nunbhakdi-CraigV, Sontag E (2013) Leucine carboxyl methyltransferase 1 (LCMT1)-dependent methylation regulates the association of protein phosphatase 2A and Tau protein with plasma membrane microdomains in neuroblastoma cells. J Biol Chem 288, 27396-27405.
39. Tanimukai H, Grundke-Iqbal I, Iqbal K (2005) Up-regulation of inhibitors of protein phosphatase-2A in Alzheimer's disease. Am J Pathol 166, 1761-1771.
40. Chen S, Li B, Grundke-Iqbal I, IqbalK(2008) I1PP2A affects tau phosphorylation via association with the catalytic sub unit of protein phosphatase 2A. J Biol Chem 283, 10513-10521.
41. Arif M, Wei J, Zhang Q, Liu F, Basurto-Islas G, Grundke-Iqbal I, Iqbal K (2014) Cytoplasmic retention of protein phosphatase 2A inhibitor 2 (I2PP2A) induces Alzheimer-like abnormal hyperphosphorylation of Tau. J Biol Chem 289, 27677-27691.
42. Wang X, Blanchard J, Tung YC, Grundke-Iqbal I, Iqbal K (2015) Inhibition of protein phosphatase-2A (PP2A) by I1PP2A leads to hyperphosphorylation of tau, neurodegeneration, and cognitive impairment in rats. J Alzheimers Dis 45, 423-435.
43. Schmidt K, Kins S, Schild A, Nitsch RM, Hemmings BA, Gotz J (2002) Diversity, developmental regulation and distribution of murine PR55/B subunits of protein phosphatase 2A. Eur J Neurosci 16, 2039-2048.
44. Martens E, Stevens I, Janssens V, Vermeesch J, Gotz J, Goris J, Van Hoof C (2004) Genomic organisation, chromosomal localisation tissue distribution and developmental regulation of the PR61/B' regulatory subunits of protein phosphatase 2A in mice. J Mol Biol 336, 971-986.
45. Hendrix P, Mayer-Jackel RE, Cron P, Goris J, Hofsteenge J, Merlevede W, Hemmings BA (1993) Structure and expression of a 72-kda regulatory subunit of protein phosphatase 2A. Evidence for different size forms produced by alternative splicing. J Biol Chem 268, 15267-15276.
46. Louis JV, Martens E, Borghgraef P, Lambrecht C, Sents W, Longin S, Zwaenepoel K, Pijnenborg R, Landrieu I, Lippens G, Ledermann B, Gotz J, Van Leuven F, Goris J, Janssens V (2011) Mice lacking phosphatase PP2A subunit PR61/b'delta (Ppp2r5d) develop spatially restricted tauopathy by deregulation of CDK5 and GSK3beta. Proc Natl Acad Sci U S A 108, 6957-6962.
47. Yao XQ, Zhang XX, YinYY, Liu B, Luo DJ, Liu D, Chen NN, Ni ZF, Wang X, Wang Q, Wang JZ, Liu GP (2011) Glycogen synthase kinase-3beta regulates Tyr307 phosphorylation of protein phosphatase-2A via protein tyrosine phosphatase 1B but not Src. Biochem J 437, 335-344.
48. Yao XQ, Li XC, Zhang XX, Yin YY, Liu B, Luo DJ, Wang Q, Wang JZ, Liu GP (2012) Glycogen synthase kinase-3beta regulates leucine-309 demethylation of protein phosphatase-2A via PPMT1 and PME-1. FEBS Lett 586, 2522-2528.